Clinical Trial

Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome Platform

Study acronym: OGNOME-REG
Recruiting
View on ClinicalTrials.gov →
Summary
This registry prospectively collects anonymized free-text symptom descriptions submitted voluntarily by adults through the OpenGenome platform at opengenome.bio. For each submission, the system retrieves real biomedical literature from PubMed and ClinicalTrials.gov in parallel, applies a constrained reasoning model operating under a strict output schema, and returns a structured biological signal report. The study evaluates the internal consistency of extracted signals, the calibration of confidence scores relative to dataset size and symptom specificity, and the distribution of biological signal categories across a large anonymous population. No intervention is assigned. No participant contact occurs. All data is anonymized at the point of collection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-05-05; most recent amendment 2026-05-16.
Trial Details
NCT Number NCT07578610
Lead Sponsor OpenGenome
Conditions Signs and Symptoms, Fever, Myalgia, Skin Diseases, Hemorrhagic Fever With Renal Syndrome, Zoonoses
Enrollment 1,000 participants
Start Date 2026-05-05
Primary Completion 2028-05-05 (estimated)
Study Completion 2028-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-19